Intuitive Surgical (ISRG) Earns Daily News Impact Rating of 0.20
Media coverage about Intuitive Surgical (NASDAQ:ISRG) has been trending somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Intuitive Surgical earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave news headlines about the medical equipment provider an impact score of 45.4937419563705 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:
- Top-End Metrics for Earnings Visibility Keep Intuitive Surgical (ISRG) a Strong Buy (investorplace.com)
- Breakfast Technical Briefing on Medical Equipment Stocks – Intuitive Surgical, AcelRx Pharma, GenMark Diagnostics, and Lantheus (menafn.com)
- Cramer Remix: Forget the $450M painting, Intuitive Surgical is the da Vinci of stocks (finance.yahoo.com)
- Breakfast Technical Briefing on Medical Equipment Stocks — Intuitive Surgical, AcelRx Pharma, GenMark Diagnostics, and Lantheus (bizjournals.com)
- Intuitive Surgical Hits a 52-Week High on Solid Prospects (finance.yahoo.com)
A number of research firms have recently commented on ISRG. Vetr raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $113.37 price objective for the company in a research note on Thursday, August 17th. Wedbush reaffirmed a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 10th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $436.00 price objective for the company in a research note on Tuesday, November 14th. Morgan Stanley reaffirmed an “overweight” rating and set a $118.89 price objective (up previously from $105.56) on shares of Intuitive Surgical in a research note on Tuesday, July 25th. Finally, Canaccord Genuity reaffirmed a “hold” rating and set a $111.11 price objective (up previously from $96.67) on shares of Intuitive Surgical in a research note on Wednesday, July 26th. Five equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $155.78.
Intuitive Surgical (NASDAQ ISRG) traded up $4.68 during mid-day trading on Tuesday, hitting $397.71. The company had a trading volume of 360,588 shares, compared to its average volume of 966,088. Intuitive Surgical has a twelve month low of $203.57 and a twelve month high of $400.00. The firm has a market cap of $43,950.00, a price-to-earnings ratio of 51.94, a P/E/G ratio of 5.45 and a beta of 0.46.
Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.99 by $0.78. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The firm had revenue of $806.10 million for the quarter, compared to analyst estimates of $753.25 million. During the same period last year, the company earned $2.06 earnings per share. The firm’s revenue for the quarter was up 18.0% on a year-over-year basis. research analysts forecast that Intuitive Surgical will post 7.85 earnings per share for the current year.
In other news, CFO Marshall Mohr sold 6,000 shares of the firm’s stock in a transaction on Monday, October 30th. The stock was sold at an average price of $372.22, for a total transaction of $2,233,320.00. Following the transaction, the chief financial officer now directly owns 12,316 shares of the company’s stock, valued at $4,584,261.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Keith R. Leonard sold 854 shares of the firm’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $1,000.00, for a total value of $854,000.00. Following the transaction, the director now directly owns 754 shares in the company, valued at $754,000. The disclosure for this sale can be found here. Insiders sold 36,156 shares of company stock worth $14,941,252 over the last ninety days. 2.20% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: This report was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this report on another site, it was stolen and republished in violation of US & international trademark & copyright law. The original version of this report can be accessed at https://theolympiareport.com/2017/11/21/intuitive-surgical-isrg-earns-daily-news-impact-rating-of-0-20.html.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.